Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL, Shaham B, Weiss PF, Horkayne-Szakaly I, Targoff IN, Miller FW, Mammen AL (2017) Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients
Common side effects include nausea, vomiting, diarrhea, abdominal pain, or constipation
Hence, in case of persistent albuminuria and/or uncontrolled metabolic risks (i.e., inadequate glycemic control, hypertension, overweight/obesity) on SGLT2i therapy, GLP-1RAs should be considered as the preferential add-on therapy in T2DM patients with chronic kidney disease
Semaglutide, Tirzepatide, and Sulfur Burps Sulfur burps may not appear as a separate line in every medicine label, but belching, reflux, dyspepsia, flatulence, nausea, vomiting, constipation, abdominal pain, and delayed gastric emptying are relevant GLP-1 effects